252 related articles for article (PubMed ID: 35372065)
1. Clinical Outcomes of MRI-Guided Adaptive Brachytherapy for Each Fraction in Locally Advanced Cervical Cancer: A Single Institution Experience.
Chi Y; Pan Y; Zhang N; Han D; Guo X; Mao Z; Cheng G
Front Oncol; 2022; 12():841980. PubMed ID: 35372065
[TBL] [Abstract][Full Text] [Related]
2. MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong.
Wu PY; Wong TPW; Yip YYC; Chang TYA; Chan LKL; Lee MCH; Law LYA; Yeung MWR; Soong SI
Brachytherapy; 2019; 18(2):171-179. PubMed ID: 30581053
[TBL] [Abstract][Full Text] [Related]
3. Analysis of dose-effect relationship between DVH parameters and clinical prognosis of definitive radio(chemo)therapy combined with intracavitary/interstitial brachytherapy in patients with locally advanced cervical cancer: A single-center retrospective study.
Zhang N; Tang Y; Guo X; Mao Z; Yang W; Cheng G
Brachytherapy; 2020; 19(2):194-200. PubMed ID: 31791712
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional experience.
Lakosi F; de Cuypere M; Viet Nguyen P; Jansen N; Warlimont B; Gulyban A; Gennigens C; Seidel L; Delbecque K; Coucke P; Hermesse J; Kridelka F
Acta Oncol; 2015; 54(9):1558-66. PubMed ID: 26406152
[TBL] [Abstract][Full Text] [Related]
5. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
6. High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes.
le Guyader M; Lam Cham Kee D; Thamphya B; Schiappa R; Gautier M; Chand-Fouche ME; Hannoun-Levi JM
Clin Transl Radiat Oncol; 2022 Jan; 32():15-23. PubMed ID: 34816022
[TBL] [Abstract][Full Text] [Related]
7. Hybrid tandem and ovoids brachytherapy in locally advanced cervical cancer: impact of dose and tumor volume metrics on outcomes.
Rivera A; Wassel M; Brodin PN; Yaparpalvi R; Velten C; Kabarriti R; Garg M; Kalnicki S; Mehta KJ
J Contemp Brachytherapy; 2021 Apr; 13(2):158-166. PubMed ID: 33897789
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of local recurrence pattern by computed tomography image-guided intracavitary and interstitial brachytherapy for locally advanced cervical cancer in a single Japanese institution.
Umezawa R; Tokunaga H; Yamamoto T; Shigeta S; Takahashi N; Takeda K; Suzuki Y; Kishida K; Ito K; Kadoya N; Shimada M; Jingu K
Brachytherapy; 2023; 22(4):477-486. PubMed ID: 37208225
[TBL] [Abstract][Full Text] [Related]
9. Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: Clinical outcome and prognostic factors.
Ka K; Laville A; Rassy E; Ayachi RE; Pautier P; Ba MB; Bockel S; Achkar S; Espenel S; Maulard A; Morice P; Gouy S; Haie-Meder C; Sun R; Chargari C
Gynecol Oncol; 2023 Jan; 168():32-38. PubMed ID: 36370612
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience.
Nomden CN; de Leeuw AA; Roesink JM; Tersteeg RJ; Moerland MA; Witteveen PO; Schreuder HW; van Dorst EB; Jürgenliemk-Schulz IM
Radiother Oncol; 2013 Apr; 107(1):69-74. PubMed ID: 23639580
[TBL] [Abstract][Full Text] [Related]
11. The MRI-guided two adaptive brachytherapy fractions versus one adaptive brachytherapy fraction in one application for the cervical cancer: a retrospective study.
Song S; Han D; Zhang N; Mao Z; Guo X; Cheng G
Radiat Oncol; 2023 Mar; 18(1):46. PubMed ID: 36879287
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of single insertion accelerated MR-image guided brachytherapy following chemo-radiation in locally advanced cervix cancer: modifying our EMBRACE during the COVID pandemic.
Stevens MJ; Ko F; Martland J; Brown R; Bell L; Atyeo J; Yim J
Radiat Oncol; 2023 Mar; 18(1):54. PubMed ID: 36941643
[TBL] [Abstract][Full Text] [Related]
13. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis.
Schmid MP; Kirisits C; Nesvacil N; Dimopoulos JC; Berger D; Pötter R
Radiother Oncol; 2011 Sep; 100(3):468-72. PubMed ID: 21924510
[TBL] [Abstract][Full Text] [Related]
14. An Asian multi-national multi-institutional retrospective study comparing intracavitary versus the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical carcinoma.
Murakami N; Ando K; Murata M; Murata K; Ohno T; Aoshika T; Kato S; Okonogi N; Saito AI; Kim JY; Yoshioka Y; Sekii S; Tsujino K; Lowanichkiattikul C; Pattaranutaporn P; Kaneyasu Y; Nakagawa T; Watanabe M; Uno T; Umezawa R; Jingu K; Kanemoto A; Wakatsuki M; Shirai K; Igaki H; Itami J
J Radiat Res; 2022 May; 63(3):412-427. PubMed ID: 35446962
[TBL] [Abstract][Full Text] [Related]
15. Intracavitary/Interstitial Applicator Plus Distal Parametrial Free Needle Interstitial Brachytherapy in Locally Advanced Cervical Cancer: A Dosimetric Study.
Qu HD; Han DM; Zhang N; Mao Z; Cheng GH
Front Oncol; 2020; 10():621347. PubMed ID: 33680943
[TBL] [Abstract][Full Text] [Related]
16. Dose-effect relationship between dose-volume parameters of residual gross tumor volume and clinical prognosis in MRI-guided adaptive brachytherapy for locally advanced cervical cancer: a single-center retrospective study.
Ke T; Wang J; Zhang N; Zhao H; Guo X; Zhao Z; Mao Z; Cheng G
Strahlenther Onkol; 2023 Feb; 199(2):131-140. PubMed ID: 36109399
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R
Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808
[TBL] [Abstract][Full Text] [Related]
18. Magnetic Resonance Image Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: An Experience From a Tertiary Cancer Center in a Low and Middle Income Countries Setting.
Mahantshetty U; Krishnatry R; Hande V; Jamema S; Ghadi Y; Engineer R; Chopra S; Gurram L; Deshpande D; Shrviastava S
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):608-617. PubMed ID: 29280456
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric and clinical outcomes of CT based HR-CTV delineation for HDR intracavitary brachytherapy in carcinoma cervix - a retrospective study.
Bandyopadhyay A; Ghosh AK; Chhatui B; Das D
Rep Pract Oncol Radiother; 2021; 26(2):170-178. PubMed ID: 34211766
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
